CH691791A8 - Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung. - Google Patents

Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung. Download PDF

Info

Publication number
CH691791A8
CH691791A8 CH01664/96A CH166496A CH691791A8 CH 691791 A8 CH691791 A8 CH 691791A8 CH 01664/96 A CH01664/96 A CH 01664/96A CH 166496 A CH166496 A CH 166496A CH 691791 A8 CH691791 A8 CH 691791A8
Authority
CH
Switzerland
Prior art keywords
notroper
effect
pharmaceutical composition
composition against
against alcohol
Prior art date
Application number
CH01664/96A
Other languages
English (en)
Other versions
CH691791A5 (de
Inventor
Tatyana Dmitrievna Soldatenkova
Tatyana Tikhonovna Kondrashova
Julia Vasilievna Gudkova
Natalya Mikhailovna Burbenskaya
Irina Alexeevna Komissarova
Original Assignee
Tatyana Dmitrievna Soldatenkova
Tatyana Tikhonovna Kondrashova
Julia Vasilievna Gudkova
Natalya Mikhailovna Burbenskaya
Irina Alexeevna Komissarova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to RU9595100307A priority Critical patent/RU2097034C1/ru
Priority to JP8521587A priority patent/JPH09510738A/ja
Priority to PCT/RU1996/000006 priority patent/WO1996021446A1/ru
Priority to US08/704,745 priority patent/US5798371A/en
Priority to DE19626431A priority patent/DE19626431B4/de
Priority claimed from FR9608205A external-priority patent/FR2750605B1/fr
Application filed by Tatyana Dmitrievna Soldatenkova, Tatyana Tikhonovna Kondrashova, Julia Vasilievna Gudkova, Natalya Mikhailovna Burbenskaya, Irina Alexeevna Komissarova filed Critical Tatyana Dmitrievna Soldatenkova
Priority to CH01664/96A priority patent/CH691791A8/de
Publication of CH691791A5 publication Critical patent/CH691791A5/de
Publication of CH691791A8 publication Critical patent/CH691791A8/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH01664/96A 1995-01-13 1996-07-03 Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung. CH691791A8 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
RU9595100307A RU2097034C1 (ru) 1995-01-13 1995-01-13 Фармацевтический препарат антиалкогольного и ноотропного действия
JP8521587A JPH09510738A (ja) 1995-01-13 1996-01-04 禁酒及びヌートロピック効果を付与された医薬組成物
PCT/RU1996/000006 WO1996021446A1 (fr) 1995-01-13 1996-01-04 Composition pharmaceutique a proprietes antialcooliques et nootropes
US08/704,745 US5798371A (en) 1995-01-13 1996-01-04 Pharmaceutical composition endowed with an antialcoholic and nootropic effect
DE19626431A DE19626431B4 (de) 1995-01-13 1996-07-01 Verwendung einer pharmazeutische Komposition mit antialkoholischer und nootroper Wirkung
CH01664/96A CH691791A8 (de) 1995-01-13 1996-07-03 Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
RU9595100307A RU2097034C1 (ru) 1995-01-13 1995-01-13 Фармацевтический препарат антиалкогольного и ноотропного действия
DE19626431A DE19626431B4 (de) 1995-01-13 1996-07-01 Verwendung einer pharmazeutische Komposition mit antialkoholischer und nootroper Wirkung
FR9608205A FR2750605B1 (fr) 1995-01-13 1996-07-02 Composition pharmaceutique a effets antialcooliques et nootropes
CH01664/96A CH691791A8 (de) 1995-01-13 1996-07-03 Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung.

Publications (2)

Publication Number Publication Date
CH691791A5 CH691791A5 (de) 2001-10-31
CH691791A8 true CH691791A8 (de) 2002-03-15

Family

ID=27428256

Family Applications (1)

Application Number Title Priority Date Filing Date
CH01664/96A CH691791A8 (de) 1995-01-13 1996-07-03 Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung.

Country Status (5)

Country Link
JP (1) JPH09510738A (de)
CH (1) CH691791A8 (de)
DE (1) DE19626431B4 (de)
RU (1) RU2097034C1 (de)
WO (1) WO1996021446A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2750605B1 (fr) * 1995-01-13 1998-09-25 Komissarova Irina Alexeevna Composition pharmaceutique a effets antialcooliques et nootropes
RU2097034C1 (ru) * 1995-01-13 1997-11-27 Ирина Алексеевна Комиссарова Фармацевтический препарат антиалкогольного и ноотропного действия
RU2561063C1 (ru) * 2014-07-01 2015-08-20 Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон") Способ коррекции неврологических нарушений при хронической алкогольной интоксикации
JP2018127427A (ja) * 2017-02-10 2018-08-16 味の素株式会社 唾液分泌促進剤、ならびにこれを配合した食品組成物、および口腔用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405629A (en) * 1979-05-07 1983-09-20 Massachusetts Institute Of Technology Process for increasing glycine levels in the brain and spinal cord
US4761429A (en) * 1985-07-22 1988-08-02 Kenneth Blum Enkephalinase and endorphinase inhibitors as anti-craving compositions
US5019558A (en) * 1988-05-09 1991-05-28 Georges Cehovic Method for treating memory disturbances using arginine aspartate
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
EP0575613B1 (de) * 1992-01-10 1998-07-22 KOMISSAROVA, Irina Alexeevna Verwendung der aminosäure glycin zur herstellung von arzneimitteln mit antistress-, stressschutz- und nootroper wirkung
RU2097034C1 (ru) * 1995-01-13 1997-11-27 Ирина Алексеевна Комиссарова Фармацевтический препарат антиалкогольного и ноотропного действия

Also Published As

Publication number Publication date
RU2097034C1 (ru) 1997-11-27
DE19626431B4 (de) 2011-03-17
DE19626431A1 (de) 1998-01-08
JPH09510738A (ja) 1997-10-28
WO1996021446A1 (fr) 1996-07-18
CH691791A5 (de) 2001-10-31

Similar Documents

Publication Publication Date Title
DE69600065D1 (de) Dermatologische und/oder pharmazeutische Zubereitung, ihre Herstellung und Anwendung
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
DE69525148D1 (de) Pharmazeutische formulierung
DE122005000024I1 (de) Darifenacin enthaltende Pharmazeutische Zubereitungen.
DE69606028D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
BR9506119A (pt) Composição farmacêutica e forma de dosagem farmacêutica unitária
PT861666E (pt) Composicao farmaceutica para utilizacao no tratamento da diabetes
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
DE69300913D1 (de) Polymorph Terazosin und pharmazeutische Zusammenstellung.
ATE288419T1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
DE59704397D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE59607535D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
DE69704060D1 (de) Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
BR9509688A (pt) Composto e composição farmacêutica
DE58905324D1 (de) Mittel gegen protozoen bei insekten.
DE69614407D1 (de) Pharmazeutische zusammensetzungen
ATE252096T1 (de) Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
DE59505714D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE69611082D1 (de) Bertholletia enthaltende kosmetische oder pharmazeutische,insbesondere dermatologische zusammensetzung
ATE270272T1 (de) C11-oxymyl- and hydroxylamino-prostaglandine und ihre anwendung als arzneimittel
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung

Legal Events

Date Code Title Description
PL Patent ceased